ReviewClinical and experimental emergency medicine2016
Pulmonary embolism: the diagnosis, risk-stratification, treatment and disposition of emergency department patients.
Review in Clinical and experimental emergency medicine, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 33 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
33 citing papers in PubMed.
- Serum Glycoprotein VI in Acute Pulmonary Embolism: Association With Radiological Thrombus Burden and Clinical Risk Indicators.Canadian respiratory journal · 2026Article
- Hampton's Hump-A Rare Radiological Feature in Patients with Pulmonary Embolism in a Single-Center Study.Journal of clinical medicine · 2025Article
- Review
- Article
- A Novel Tool for Predicting an Abnormal Echocardiogram in Patients with Pulmonary Embolism: The PEACE Score.The Journal of emergency medicine · 2024Article
- Article
- Prediction of mortality in patients with secondary pulmonary embolism based on primary admission indication: A short communication.Biomolecules & biomedicine · 2024Article
- The Utilisation of Computed Tomography Pulmonary Angiography in a Regional Victorian Emergency Department.Cureus · 2023Article
- Streamlining Patient Management of Suspected COVID-19 Patients in the Emergency Department: Incorporation of Pulmonary CT Angiography into the Triaging Algorithm.Diagnostics (Basel, Switzerland) · 2022Article
- Clot In Transit in a Patient with Protein S Deficiency.European journal of case reports in internal medicine · 2022Article
- Diagnostic accuracy of ultrasound-guided core needle biopsy versus incisional biopsy in soft tissue sarcoma: an institutional experience.Scientific reports · 2021Article
- Liver injury in COVID-19: Detection, pathogenesis, and treatment.World journal of gastroenterology · 2021Review
- Post-acute COVID-19 syndrome.Nature medicine · 2021Review
- Pulmonary Artery Filling Defects in COVID-19 Patients Revealed Using CT Pulmonary Angiography: A Predictable Complication?BioMed research international · 2021Article
- Role of Chest CT in COVID-19.Journal of clinical imaging science · 2021Review
- Contemporary Catheter-Based Treatment Options for Management of Acute Pulmonary Embolism.Current treatment options in cardiovascular medicine · 2021Review
- Differential diagnostic factors of type 1 and type 2 myocardial infarction in patients with elevated cardiac troponin levels.Clinical and experimental emergency medicine · 2020Article
- Acute Pulmonary Embolism in Patients with COVID-19 at CT Angiography and Relationship to d-Dimer Levels.Radiology · 2020Article
- COVID-19 and the endothelium.Clinical hemorheology and microcirculation · 2020Article
- Efficacy of Computed Tomography Pulmonary Angiography as Non-invasive Imaging Biomarker for Risk Stratification of Acute Pulmonary Embolism.Journal of clinical imaging science · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The diagnosis or exclusion of pulmonary embolism (PE) remains challenging for emergency physicians. Symptoms can be vague or non-existent, and the clinical presentation shares features with many other common diagnoses. Diagnostic testing is complicated, as biomarkers, like the D-dimer, are frequently false positive, and imaging, like computed tomography pulmonary angiography, carries risks of radiation and contrast dye exposure. It is therefore incumbent on emergency physicians to be both vigilant and thoughtful about this diagnosis. In recent years, several advances in treatment have also emerged. Novel, direct-acting oral anticoagulants make the outpatient treatment of low risk PE easier than before. However, the spectrum of PE severity varies widely, so emergency physicians must be able to risk-stratify patients to ensure the appropriate disposition. Finally, PE response teams have been developed to facilitate rapid access to advanced therapies (e.g., catheter directed thrombolysis) for patients with high-risk PE. This review will discuss the clinical challenges of PE diagnosis, risk stratification and treatment that emergency physicians face every day.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.